A Study of Azelaic Acid (AzA) 15% Gel in the Treatment of Seborrheic Dermatitis of the Face

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE2

Total Enrollment

48 participants

Study Classification

INTERVENTIONAL

Study Start Date

2006-12-31

Study Completion Date

2007-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is to determine whether a medication on the market for other indications is effective and safe in treating seborrheic dermatitis of the face.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

A Study of Azelaic Acid (AzA) 15% in Topical Treatment of Mild to Moderate Perioral Dermatitis

NCT00403949

Perioral Dermatitis

COMPLETED PHASE2

Safety and Efficacy of SRD441 Ointment in Patients With Atopic Dermatitis

NCT00882245

Atopic Dermatitis

COMPLETED PHASE2

A Study to Determine the Safety & Efficacy of ZPL-5212372 in Healthy Subjects and in Subjects With Atopic Dermatitis

NCT02795832

Atopic Dermatitis

COMPLETED PHASE1/PHASE2

Efficacy and Safety of a Retinoid for the Treatment of Severe Chronic Hand Dermatitis

NCT00124475

Hand Dermatoses

COMPLETED PHASE3

Follow-up Efficacy and Safety of Alitretinoin in Severe Chronic Hand Dermatitis

NCT00124436

Hand Dermatoses

COMPLETED PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

To test the efficacy and safety of azelaic acid 15% gel in the treatment of seborrheic dermatitis of the face

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Seborrheic Dermatitis on the Face

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

azelaic acid 15%

Group Type ACTIVE_COMPARATOR

Azelaic Acid 15% Gel

Intervention Type DRUG

15% gel, topically applied daily for six weeks

2

Inactive 15% gel base

Group Type PLACEBO_COMPARATOR

Inactive 15% gel base

Intervention Type DRUG

placebo, topically applied daily for six weeks

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Azelaic Acid 15% Gel

15% gel, topically applied daily for six weeks

Intervention Type DRUG

Inactive 15% gel base

placebo, topically applied daily for six weeks

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

\- Stable or exacerbating seborrheic dermatitis in the facial area

Exclusion Criteria

* Psoriasis
* Atopic dermatitis
* Facial acne and rosacea
* Dermatophytic skin infections
* Parkinson's disease
* Known immunosuppression; HIV infection
* Any condition requiring continuous systemic or topical corticosteroid or antimycotic therapy
* Continuous asthma inhalation treatment requiring \> 800 mg corticosteroids
* Any severe disease likely to interfere with the conduct or the planned termination of the study

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No